Skip to main content

Pamela J Lein

NIH Rank #3267
  • Program Leader
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1931492Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • VETERINARY SCIENCES

NIH Funding · FY2025

Linked Award Amount
$3.1M
Full award amounts, FY2025
Award Records
10
Records listing this PI
Award-Linked Rank
#3,267
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Pamela J Lein. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Pamela J Lein as a PI. Multi-PI records show the full award amount for context.

  • 4R01NS130659-02R01
    Do Atmospheric Ultrafine Particles Lodge in the Brain and Cause Cognitive Decline Leading to Alzheimer's Disease Related Dementias?
    $760.7K
    award amount
  • 5R01AG074709-03R01
    Traffic-related air pollution exacerbates AD-relevant phenotypes in a genetically susceptible rat model via neuroinflammatory mechanism(s)
    $745.7K
    award amount
  • 5R01ES014901-14R01
    Molecular and Cellular Basis of PCB Developmental Neurotoxicity
    $610.2K
    award amount
  • 5U54NS127758-04U54
    UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication
    $345.3K
    award amount
  • 3U54NS127758-04S3U54
    Long-Term Consequences of Acute Organophosphate Intoxication in an Adolescent Rodent Model
    $161K
    award amount
  • 3R01ES014901-14S1R01
    Molecular and Cellular Basis of PCB Developmental Neurotoxicity
    $115K
    award amount
  • 3R01AG074709-03S1R01
    Traffic-related air pollution exacerbates AD-relevant phenotypes in a genetically susceptible rat model via neuroinflammatory mechanism(s)
    $95.2K
    award amount
  • 3R01ES014901-14S2R01
    Molecular and Cellular Basis of PCB Developmental Neurotoxicity
    $95.1K
    award amount
  • 3U54NS127758-04S1U54
    UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication
    $73.7K
    award amount
  • 3U54NS127758-04S2U54
    UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication
    $73.7K
    award amount

Award organization

Organizations that administered FY2025 awards listing Pamela J Lein as a PI.

FY2025 award administered by University of California at Davis (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of California at Davis
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2835
  6. 2024
    Entered Top 25% Nationally
    Ranked #2835
  7. 2025
    $5M Cumulative Funding
  8. 2025
    R01 Grant Holder
  9. 2025
    Program/Center Grant Leader
  10. 2026
    $10M Cumulative Funding
  11. 2026
    Entered Top 10% Nationally
    Ranked #629
  12. 2026
    Entered Top 5% Nationally
    Ranked #629